We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

21 hedge funds and large institutions have $1.87M invested in Microbot Medical in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

138% more capital invested

Capital invested by funds: $787K → $1.87M (+$1.08M)

17% more funds holding

Funds holding: 18 → 21 (+3)

0.4% less ownership

Funds ownership: 0.48% → 0.08% (-0.4%)

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$425K
2
BlackRock
BlackRock
New York
+$349K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$195K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$140K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$117K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$68K
2
UBS Group
UBS Group
Switzerland
-$4.13K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
-$615
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$511K +$425K +4,839 +475%
BlackRock
2
BlackRock
New York
$346K +$349K +3,970 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$312K +$195K +2,220 +167%
Vanguard Group
4
Vanguard Group
Pennsylvania
$266K +$140K +1,589 +110%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$116K +$117K +1,334 +133,400%
Goldman Sachs
6
Goldman Sachs
New York
$96K +$96.9K +1,104 New
Northern Trust
7
Northern Trust
Illinois
$87K +$87.6K +997 New
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$69K +$68.8K +783 New
Morgan Stanley
9
Morgan Stanley
New York
$58K +$56.5K +643 +6,430%
PFO
10
Pathstone Family Office
New Jersey
$2K +$2.19K +25 New
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$1K -$615 -7 -50%
Bank of America
12
Bank of America
North Carolina
$1K – – –
DSC
13
Duncker Streett & Co
Missouri
$1K – – –
WAM
14
Wealthspire Advisors (Maryland)
Maryland
$1K – – –
Citigroup
15
Citigroup
New York
$1K +$615 +7 New
Federated Hermes
16
Federated Hermes
Pennsylvania
$1K +$878 +10 New
Deutsche Bank
17
Deutsche Bank
Germany
$1K +$1.76K +20 +1,000%
Citadel Advisors
18
Citadel Advisors
Florida
– -$68K -740 Closed
UBS Group
19
UBS Group
Switzerland
– -$4.13K -47 -92%
AG
20
Advisor Group
Arizona
– +$88 +1 New

MBOT Hedge Fund Activity: Q1 2017 in Review

21 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2017, worth a combined $1.87M — up 138% from $787K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MBOT positions and 2 closed out — a net gain of 6 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Millennium Management, adding an estimated $425K. The largest seller was Citadel Advisors, exiting entirely with an estimated $68K sold.

  • 21 institutional investors held Microbot Medical (MBOT) as of Q1 2017, up from 18 in Q4 2016.
  • Funds reported $1.87M of Microbot Medical stock for Q1 2017, up 138% quarter-over-quarter.
  • 8 funds opened new Microbot Medical positions in Q1 2017 and 2 closed out, a net change of +6 holders.
  • The largest Microbot Medical buyer in Q1 2017 was Millennium Management, an estimated $425K added.
  • The largest Microbot Medical seller in Q1 2017 was Citadel Advisors, an estimated $68K sold.

Based on aggregated 13F filings for Q1 2017.